Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Deferasirox

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 405Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    19/08/2020 Neuland Laboratories
    India
    		 M/s. Neuland Laboratories Ltd WC-0037 Deferasirox IH, EP 2022-06-08 2025-06-16 Unit-II, Plot No.92-94, 257-259, IDA Pashmylaram, Isnapur Village, Patancheru Mandal, Sangareddy District-502319, Telengana State. India
    07/08/2024 Alembic Pharmaceuticals Limited
    India
    		 M/s. Alembic Pharmaceuticals Limited WC-0082 Deferasirox/DeferasiroxEP 2022-06-17 2025-07-02 API Division Kharakhadi, Plot No. 842-843, Kharakhadi, Padra Vadodara-391 450, Gujarat India